Tardive Dyskinesia: Moving Management Forward

CME: 1.0

December 17, 2021
/ Print / Reprints /
| Share More
/ Text Size+

Expert faculty will discuss risk factors for and identification of Tardive Dyskinesia, treatment recommendations according to current guidelines. and the latest evidence on emerging therapies and conclude with the potential impact of clinical trial data on patients’ lives.

Post a comment to this article